S. Ogasawara

Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes

Y. Tomino, I. Narita, K. Yamagata, 2012, Diabetes Care.

Urinary A- and C-megalin predict progression of diabetic kidney disease: a retrospective cohort study

N. Kitamura, I. Narita, Keiko Kabasawa, 2021 .

Role of megalin, a proximal tubular endocytic receptor, in the pathogenesis of diabetic and metabolic syndrome‐related nephropathies: protein metabolic overload hypothesis

F. Gejyo, S. Nishi, Y. Oyama, 2005, Nephrology.

GLCCI1 is a novel protector against glucocorticoid‐induced apoptosis in T cells

H. Takematsu, Y. Ishigaki, Y. Nishibori, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.

N. Kitamura, I. Narita, M. Hosojima, 2022, Journal of diabetes and its complications.

Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli.

M. Hara, T. Yanagihara, I. Kihara, 2010, Human pathology.

Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.

Y. Tomino, K. Asanuma, M. Hara, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin

Y. Tomino, K. Yan, K. Yamagata, 2012, Diabetologia.